The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Offset Mechanisms in Evaluation of Lumbar Medial Branch Blocks (OMEGA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT05961800
Recruitment Status : Recruiting
First Posted : July 27, 2023
Last Update Posted : July 27, 2023
Sponsor:
Information provided by (Responsible Party):
Benedict Alter, University of Pittsburgh

Brief Summary:
This study examines the relationship between central nervous system (CNS) mechanisms of pain inhibition and the pain relief that occurs following a lumbar medial branch block (MBB).

Condition or disease Intervention/treatment Phase
Pain, Chronic Facet Joint Pain Pain, Procedural Analgesia Behavioral: Cutaneous Probe Behavioral: Quantitative Sensory Testing Behavioral: Computer Tasks Not Applicable

Detailed Description:
This study examines the relationship between central nervous system (CNS) mechanisms of pain inhibition and the pain relief that occurs following a commonly-performed nerve block used to diagnose and treat chronic low back pain. Patients scheduled for lumbar medial branch blocks as part of routine clinical care will arrive to clinic prior to the block for quantitative sensory testing procedures that measure CNS pain modulation. Patients will then undergo treatment as usual with their block, subsequently reporting low back pain intensity in a pain diary.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 40 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Intervention Model Description: Quantitative Sensory Testing
Masking: None (Open Label)
Primary Purpose: Basic Science
Official Title: OMEGA Study: Offset Mechanisms in Evaluation of Lumbar Medial Branch Block
Actual Study Start Date : July 5, 2023
Estimated Primary Completion Date : June 2025
Estimated Study Completion Date : June 2025

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Quantitative Sensory Testing
Participants with chronic low back pain and a scheduled lumbar medial branch block undergo quantitative sensory testing.
Behavioral: Cutaneous Probe
A computer-controlled probe delivers temperatures to the skin to measure pain, offset analgesia and onset hyperalgesia.

Behavioral: Quantitative Sensory Testing
Standard methods involving pinprick, pressure, heat, and cold applied to the skin are used to measure sensation and pain

Behavioral: Computer Tasks
Quantitative Sensory Testing (QST) and computer tasks are used to measure changes in pain intensity.




Primary Outcome Measures :
  1. Offset analgesia and onset hyperalgesia [ Time Frame: during this portion of the study visit (30 minutes) ]
    Pain intensity difference during heat stimuli measured on a 0-100 sliding scale (0 is no pain, 100 is the most intense pain imaginable) at baseline

  2. Low back pain intensity change [ Time Frame: Immediately after lumbar medial branch block and up to 16 hours after lumbar medial branch block ]
    Patients respond to the question "How would you rate your back pain right now?" from 0 (no pain) to 10 (worst imaginable pain) to see how intense their back pain is each hour after the lumbar medial branch block.


Secondary Outcome Measures :
  1. Duration of low back pain [ Time Frame: Baseline ]
    Participant self-reports the number of years they have experienced low back pain. The number of years for each participant will be reported.

  2. PEG: A Three-Item Scale Assessing Pain Intensity and Interference [ Time Frame: Baseline ]
    Assessment for self-reported average pain and pain interference within past 7 days. Responses range from 0 (no pain) to 10 (pain as bad as you can imagine). Total scores range from 0-30, and higher scores indicate more pain interference.

  3. Baseline Back Pain Intensity [ Time Frame: Baseline ]
    Assessment for determining how much a person hurts with a question ranked on a 11-point scale, from "0 = no pain" to "10 = worst imaginable pain." The minimum raw summed score is 0 and the maximum score is 10. Lower raw response scores suggest lower pain intensity and better outcomes.

  4. PROMIS Pain Interference 4a [ Time Frame: Baseline ]
    Assessment for self-reported consequences of pain with 4 questions ranked on a 5-point scale, from "not at all" to "very much". The minimum raw summed score is 4 and the maximum score is 20. Lower scores suggest better outcomes.

  5. PROMIS Physical Function- 6b [ Time Frame: Baseline ]
    Assessment for self-reported capability with 6 qualitatively scaled questions ranked on a 5-point scale, from "without any difficulty" to "unable to do" or "not at all" to "cannot do." The minimum raw summed score is 6 and the maximum score is 30.

  6. PROMIS Sleep Disturbance 6a [ Time Frame: Baseline ]
    Assessment for self-reported perceptions of sleep quality and sleep depth with 6 questions ranked on a 5-point scale. The minimum raw summed score is 6 and the maximum score is 30. Lower scores suggest better outcomes.

  7. 6-item Pain Catastrophizing Scale [ Time Frame: Baseline ]
    Standardized survey score assessing pain perception before the study procedures begin. Rumination subscale score ranges from 0-16. Magnification subscale score ranges 0-12. Helplessness subscale score ranges from 0-24. Total score can be calculated by summing subscales. Total score ranges from 0-52, with higher scores indicating more pain catastrophizing.

  8. Patient Health Questionnaire (PHQ-2) [ Time Frame: Baseline ]

    The PHQ-2 inquires about the frequency of depressed mood and anhedonia over the past two weeks. The PHQ-2 includes the first two items of the PHQ-9. A PHQ-2 score ranges from 0-6. The authors identified a score of 3 as the optimal cutpoint when using the PHQ-2 to screen for depression.

    If the score is 3 or greater, major depressive disorder is likely.


  9. PROMIS 4-item Depression [ Time Frame: Baseline ]
    Assessment for self-reported negative mood and views of self with 4 questions ranked on a 5-point scale, from "never" to "always". The minimum raw summed score is 4 and the maximum score is 20. Lower t-scores suggest better outcomes.

  10. PROMIS 4-item Anxiety [ Time Frame: Baseline ]
    Assessment for self-reported fear, anxious misery, hyperarousal, and somatic symptoms with 4 questions ranked on a 5-point scale, from "never" to "always". The minimum raw summed score is 4 and the maximum score is 20. Lower scores suggest better outcomes.

  11. Areas of Pain Body Map [ Time Frame: Baseline ]
    The digital body figure contains 36 anterior regions and 38 posterior regions on which participants can mark areas in which they experience chronic pain. The number of pain areas each participant recorded will be reported, with a possibility of 74 total regions.

  12. Treatment Expectancy [ Time Frame: Baseline ]
    Assessment for the subject's expectations of treatment effec prior to lumbar medial branch block. Scores range from 0 (not at all) to 4 (very much), with total scores ranging from 0-24. Higher scores indicate higher expectations of the low back pain treatement.

  13. Patient Global Impression of Change [ Time Frame: Immediately after lumbar medial branch block ]
    The subject's impression of the impact of the lumbar medial branch block on their pain and function will be measured with a 7-item scale (1 = very much worse, 2 = much worse, 3 = minimally worse, 4 = no change, 5 = minimally improved, 6 = much improved, 7 = very much improved).

  14. Situational pain catastrophizing scale (S-PCS) [ Time Frame: Immediately after lumbar medial branch block ]
    Standardized survey score assessing pain perception immediately following the lumbar medial branch block. Scores range from 0-24, with higher scores representing more pain catastrophizing.

  15. Pain intensity during QST [ Time Frame: during this portion of the study visit (60 minutes) ]
    Changes in pain intensity during quantitative sensory tests measured on a 0-100 sliding scale (0 is no pain, 100 is the most intense pain imaginable)

  16. Baseline back pain intensity [ Time Frame: baseline ]
    Patients respond to the question "How would you rate your back pain on average?" from 0 (no pain) to 10 (worst imaginable pain) to see how intense their back pain is before the lumbar medial branch block.

  17. Back pain intensity after lumbar medial branch block [ Time Frame: Immediately after lumbar medial branch block and up to 16 hours after lumbar medial branch block ]
    Patients respond to the question "How would you rate your back pain right now?" from 0 (no pain) to 10 (worst imaginable pain) to see how intense their back pain is each hour after the lumbar medial branch block.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Scheduled for lumbar MBB in UPMC Pain Management clinics
  • Age > 18 years old
  • Predominantly axial chronic low back pain at least 3 months on a daily basis
  • Must meet the minimum criteria for cognitive function using the PROMIS 2-item cognitive screener (>3)
  • Low back pain intensity of > 3/10
  • Willing and able to receive study-related phone calls

Exclusion Criteria:

  • History of spine surgery at the level of the lumbar MBB
  • Active worker's compensation or litigation claims
  • New pain and/or psychiatric treatments within 2 weeks of enrollment
  • Not fluent in English and/or not able to complete the questionnaires
  • Any clinically unstable systemic illness that is judged to interfere with the study

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05961800


Contacts
Layout table for location contacts
Contact: Maya L Maurer, BS 412-665-8052 mam708@pitt.edu
Contact: Benedict J Alter, MD, PhD 412-677-0575 alterbj@upmc.edu

Locations
Layout table for location information
United States, Pennsylvania
UPMC St. Margaret Recruiting
Pittsburgh, Pennsylvania, United States, 15215
Contact: Maya L Maurer, BS    412-665-8052    mam708@pitt.edu   
Contact: Benedict J Alter, MD, PhD    412-677-0575    alterbj@upmc.edu   
Principal Investigator: Benedict J Alter, MD, PhD         
Sponsors and Collaborators
University of Pittsburgh
Investigators
Layout table for investigator information
Principal Investigator: Benedict J Alter, MD, PhD University of Pittsburgh
Layout table for additonal information
Responsible Party: Benedict Alter, Assistant Professor, University of Pittsburgh
ClinicalTrials.gov Identifier: NCT05961800    
Other Study ID Numbers: STUDY23040122
First Posted: July 27, 2023    Key Record Dates
Last Update Posted: July 27, 2023
Last Verified: July 2023
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Yes
Plan Description: Individual participant data will be available, including data dictionaries, after publication per journal and funding protocols. The statistical analysis plan and analytic code will also be available per the same protocols.
Supporting Materials: Study Protocol
Statistical Analysis Plan (SAP)
Informed Consent Form (ICF)
Clinical Study Report (CSR)
Analytic Code
Time Frame: Data will become available after publication per journal and funding entity protocols.
Access Criteria: Data will be made available by reasonable request and/or per journal and funding entity protocols.

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Benedict Alter, University of Pittsburgh:
lumbar
medial branch block
offset analgesia
onset hyperalgesia
QST
quantitative sensory testing
Additional relevant MeSH terms:
Layout table for MeSH terms
Arthralgia
Chronic Pain
Pain, Procedural
Joint Diseases
Musculoskeletal Diseases
Pain
Neurologic Manifestations